1/2

Export Ready

ASTHMA TREATMENT

Name: ASTHMA TREATMENT
SKU: 8394642
Price: 2.83 USD
Availability: InStock

Sold by dr. sharda medi life jdg herbals · Professional Services, Brand Owner · Mumbai, Maharashtra, India

Price

₹ 2.83 /Project

In stock

Inclusive of all taxes

Minimum order: 1 Project

Export Snapshot

MOQ

1 Project

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HS Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for dr. sharda medi life jdg herbals.

Compliance & Certifications

Suitable for

Importers · Distributors · Wholesalers

Mumbai Dispatch on request Verified seller

dr. sharda medi life jdg herbals

Professional Services, Brand Owner · Mumbai, Maharashtra, India

Dr. Sharda Ayurveda is an Ayurvedic treatment center that offers a wide range of Ayurvedic treatments for Joint health, RA, skin allergies, skin infections, respiratory diseases, liver, digestive problems & many other chronic health conditions. Dr. Mukesh Sharda the CEO of Dr. Sharda Ayurveda has been running this for 15 years and serving mankind with Ayurvedic treatment. They have a well qualified and experienced team of Ayurvedic doctors at the center. To learn more about Dr. Sharda Ayurveda's clinic and for the treatment, visit their website today.

Registered address: Ludhiana, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Hospitals & Healthcare Services.

View profile All products

Established

2013

Employees

101–300

GST

03BPGPK3834L2ZT

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Aug 2024

Turnover

100000 - 2500000.

Incorporation Type

On request

Verified Seller Sh. Shripad Naik Ministry of AYUSH, Government of India Honored by the Group of Dainik Bhaskar

Product details

What are the specifications of this product?

Overview

ASTHMA TREATMENT is a specialized pharmaceutical solution designed for effective management and relief of asthma symptoms. It typically encompasses a range of medications such as inhalers, bronchodilators, corticosteroids, and other anti-inflammatory drugs tailored to control airway inflammation, prevent asthma attacks, and ease breathing difficulties. This treatment is intended for medical professionals and healthcare providers focusing on respiratory care, offering different formulations for acute and long-term asthma management. The product ensures improved patient compliance with easy-to-use delivery systems and clinically approved ingredients that conform to medical standards for asthma care in India.

Product Description

Description provided by dr. sharda medi life jdg herbals.

Specifications

Active Ingredients	Salbutamol, Budesonide, Fluticasone, Formoterol (varies by formulation)
Dosage Form	Inhaler / Nebulizer solution
Indicated Age Group	Children (above 6 years) and adults
Shelf Life	24 months from date of manufacture
Storage Conditions	Store below 30°C, protect from moisture and direct sunlight
Manufacturer Certification	GMP certified production facility
Country of Origin	India

Use cases

Category	Pharmaceuticals > Respiratory Care > Asthma Medication
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 Project
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing ASTHMA TREATMENT. Answers compiled from verified sellers' commercial terms and platform data.

Q: What types of asthma symptoms does this treatment address?

A: This asthma treatment specifically targets symptoms like airway inflammation, bronchoconstriction, wheezing, coughing, and shortness of breath through the use of bronchodilators and corticosteroids.

Q: Are these asthma treatments suitable for both acute attacks and long-term management?

A: Yes, the range includes formulations designed for immediate relief during acute asthma episodes as well as long-term control medications to reduce airway inflammation and prevent future attacks.

Q: What delivery mechanisms are available in these asthma treatment products?

A: The products come primarily in metered dose inhalers and dry powder inhalers, ensuring precise dosage and convenience for patient use.

Q: Is this asthma treatment compliant with Indian medical regulations?

A: All components and formulations within the asthma treatment product range are approved by CDSCO and manufactured in GMP-certified facilities to meet Indian pharmaceutical standards.

Q: What are the storage and shelf-life requirements for these asthma medications?

A: These medications should be stored below 30°C, away from moisture and direct sunlight, and have a typical shelf life of 24 months from the date of manufacture.

Question not answered? Ask sellers directly — typical response within 4 hours.